Compare Alcon AG (ALC) vs Infosys Limited (INFY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alcon AG vs Infosys Limited — how do they compare? Alcon AG trades at $72.48 (market cap $36.44B), while Infosys Limited trades at $12.42 (market cap $50.55B). The key difference: Infosys Limited is the larger of the two by market cap, and Infosys Limited pays the higher dividend (4.16%). Which is the better fit depends on your goals.
| ALC | INFY | |
|---|---|---|
Market Cap | $36.44B | $50.55B |
Sector | Health | Technology |
52-Week High | $90.12 | $20.22 |
52-Week Low | $62.02 | $10.49 |
Enterprise Value | $40.28B | $48.30B |
Dividend Yield | 0.48% | 4.16% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About Infosys Limited
Infosys is a global leader in next-generation digital services and consulting. It enables clients in more than 50 countries to navigate their digital transformation through AI-powered cloud and data solutions.
Read more on INFY →
